Retrospective Cohort Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 16, 2022; 10(32): 11726-11742
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11726
Development and validation of novel nomograms to predict survival of patients with tongue squamous cell carcinoma
Xia-Yan Luo, Ya-Min Zhang, Run-Qiu Zhu, Shan-Shan Yang, Lu-Fang Zhou, Hui-Yong Zhu
Xia-Yan Luo, Ya-Min Zhang, Run-Qiu Zhu, Hui-Yong Zhu, Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang Province, China
Shan-Shan Yang, Department of Stomatology, Sanmen People’s Hospital, Taizhou 317100, Zhejiang Province, China
Lu-Fang Zhou, Department of Stomatology, Jiangshan People's Hospital, Quzhou 324199, Zhejiang Province, China
Author contributions: Luo XY and Zhang YM contributed equally to this work and share the first authorship; Luo XY, Zhang YM, and Zhu HY designed the research study; Zhu RQ, Yang SS, and Zhou LF collected data; Luo XY and Zhang YM analyzed the data and wrote the manuscript; All authors have read and approve the final manuscript.
Institutional review board statement: The study was reviewed and approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (Approval No. IIT20210346A).
Informed consent statement: The informed consent was exempted.
Conflict-of-interest statement: All the authors declare that they have no conflicts of interest.
Data sharing statement: The datasets of this study are available on request to the corresponding author.
STROBE statement: All the authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hui-Yong Zhu, MD, PhD, Professor, Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhejiang University School of Medicine, No. 79 Qingchun Road, Shangcheng District, Hangzhou 310003, Zhejiang Province, China. zhuhuiyong@zju.edu.cn
Received: August 8, 2022
Peer-review started: August 8, 2022
First decision: September 25, 2022
Revised: October 2, 2022
Accepted: October 17, 2022
Article in press: October 17, 2022
Published online: November 16, 2022
Core Tip

Core Tip: In order to predict prognosis more accurately and precisely, we used two cohorts to develop nomograms in predicting overall survival and cancer-specific survival of patients with tongue squamous cell carcinoma. We adhered to the Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis statement-not only evaluated these nomograms in discrimination, calibration, but also their clinical utility. Additionally, the net reclassification index was also used to assess the accuracy of them. These nomograms provide patients and clinicians with an accurate prognosis, so as to facilitate patient-clinician communications and assist clinicians in improving decision-making.